View in EDS

Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.
Authors: Hidalgo-Soto M; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain., Rodríguez-Lobato LG; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., Motlló Borrella C; Haematology Department, Hospital Parc Taulí, Sabadell, Spain., Sánchez Cayuela Á; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Lopez Pardo J; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Rosiñol L; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., Cibeira MT; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., García-Guiñon A; Haematology Department, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain., Tolosa-Ridao C; Haematology Department, Hospital Universitari MútuaTerrassa, Terrassa, Spain., Carro Arostegui I; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Sureda A; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Herranz MJ; Haematology Department, Hospital Santa Tecla, Tarragona, Spain., Abella Montreal E; Haematology Department, Hospital del Mar, Barcelona, Spain., Pelicano M; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain., Barrau Alzuria Y; Haematology Department, Institut Català D'oncologia (ICO) Tarragona, Tarragona, Spain., Cortes Sansa M; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain., Gironella M; Haematology Department, Hospital Universitari Vall D'hebron, Barcelona, Spain., González Y; Haematology Department, Institut Català D'oncologia (ICO), Girona, Spain., Fernández De Larrea C; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Source: European journal of haematology [Eur J Haematol] 2026 Jun; Vol. 116 (6), pp. 806-815. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41652820
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hidalgo-Soto+M%22">Hidalgo-Soto M</searchLink>; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Lobato+LG%22">Rodríguez-Lobato LG</searchLink>; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Motlló+Borrella+C%22">Motlló Borrella C</searchLink>; Haematology Department, Hospital Parc Taulí, Sabadell, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez+Cayuela+Á%22">Sánchez Cayuela Á</searchLink>; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez+Pardo+J%22">Lopez Pardo J</searchLink>; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rosiñol+L%22">Rosiñol L</searchLink>; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cibeira+MT%22">Cibeira MT</searchLink>; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Guiñon+A%22">García-Guiñon A</searchLink>; Haematology Department, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Tolosa-Ridao+C%22">Tolosa-Ridao C</searchLink>; Haematology Department, Hospital Universitari MútuaTerrassa, Terrassa, Spain.<br /><searchLink fieldCode="AU" term="%22Carro+Arostegui+I%22">Carro Arostegui I</searchLink>; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sureda+A%22">Sureda A</searchLink>; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Herranz+MJ%22">Herranz MJ</searchLink>; Haematology Department, Hospital Santa Tecla, Tarragona, Spain.<br /><searchLink fieldCode="AU" term="%22Abella+Montreal+E%22">Abella Montreal E</searchLink>; Haematology Department, Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pelicano+M%22">Pelicano M</searchLink>; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain.<br /><searchLink fieldCode="AU" term="%22Barrau+Alzuria+Y%22">Barrau Alzuria Y</searchLink>; Haematology Department, Institut Català D'oncologia (ICO) Tarragona, Tarragona, Spain.<br /><searchLink fieldCode="AU" term="%22Cortes+Sansa+M%22">Cortes Sansa M</searchLink>; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain.<br /><searchLink fieldCode="AU" term="%22Gironella+M%22">Gironella M</searchLink>; Haematology Department, Hospital Universitari Vall D'hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22González+Y%22">González Y</searchLink>; Haematology Department, Institut Català D'oncologia (ICO), Girona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+De+Larrea+C%22">Fernández De Larrea C</searchLink>; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228703985%22">European journal of haematology</searchLink> [Eur J Haematol] 2026 Jun; Vol. 116 (6), pp. 806-815. <i>Date of Electronic Publication: </i>2026 Feb 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell%22">Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8703985 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209024441%22">09024441 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41652820
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ejh.70126
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 806
    Titles:
      – TitleFull: Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hidalgo-Soto M
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Lobato LG
      – PersonEntity:
          Name:
            NameFull: Motlló Borrella C
      – PersonEntity:
          Name:
            NameFull: Sánchez Cayuela Á
      – PersonEntity:
          Name:
            NameFull: Lopez Pardo J
      – PersonEntity:
          Name:
            NameFull: Rosiñol L
      – PersonEntity:
          Name:
            NameFull: Cibeira MT
      – PersonEntity:
          Name:
            NameFull: García-Guiñon A
      – PersonEntity:
          Name:
            NameFull: Tolosa-Ridao C
      – PersonEntity:
          Name:
            NameFull: Carro Arostegui I
      – PersonEntity:
          Name:
            NameFull: Sureda A
      – PersonEntity:
          Name:
            NameFull: Herranz MJ
      – PersonEntity:
          Name:
            NameFull: Abella Montreal E
      – PersonEntity:
          Name:
            NameFull: Pelicano M
      – PersonEntity:
          Name:
            NameFull: Barrau Alzuria Y
      – PersonEntity:
          Name:
            NameFull: Cortes Sansa M
      – PersonEntity:
          Name:
            NameFull: Gironella M
      – PersonEntity:
          Name:
            NameFull: González Y
      – PersonEntity:
          Name:
            NameFull: Fernández De Larrea C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1600-0609
          Numbering:
            – Type: volume
              Value: 116
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European journal of haematology
              Type: main
ResultId 1